ArticleThe Lancet. Rheumatology2022

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study.

Gabriel Figueroa-Parra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.